FindTrial
Sign In

A study to assess Visual Acuity, vision related Quality of Life (QoL) among diabetic retinopathy patients.

A descriptive study to assess the Visual Acuity, vision related Quality of Life (QoL) and Patient Reported Outcome Measure (PROM) among patients with diabetic retinopathy with an intent to develop an audio care module. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/05/087010
Enrollment
200
Registered
2025-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

Control Intervention1: NIL: NIL

Sponsors

All India Institute of Medical Sciences New Delhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Type 2 Diabetic patients who attend Retina clinic, AIIMS Delhi. Patients who consent to participate in the study. Patients who can read and understand English and Hindi languages.

Exclusion criteria

Exclusion criteria: Type 2 Diabetic patients with significant diabetic related complications, other than Diabetic Retinopathy (DR). Type 2 diabetic patients with other ocular problems are excluded.

Design outcomes

Primary

MeasureTime frame
Visual Acuity Vision related quality of life Patient Related Quality of Life Timepoint: Visual Acuity - at baseline Vision related quality of life- at baseline Patient Related Quality of Life- at baseline—

Secondary

MeasureTime frame
Association between Diabetic Retinopathy and Visual Acuity. Association between Diabetic Retinopathy and vision related quality of life. Timepoint: Association between Diabetic Retinopathy and Visual Acuity - at baseline Association between Diabetic Retinopathy and vision related quality of life - at baseline—

Countries

India

Contacts

Public ContactSibi Riju

All India Institute of Medical Sciences New Delhi

sibiriju@gmail.com9958879808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026